Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Altman

Showing results (461-470 of 618) with videos related to

Pageof 62
Sort By:
Arthritis and Rheumatism|March 1, 1991
Amelioration of lapine osteoarthritis by treatment with glycosaminoglycan-peptide association complex (Rumalon)D D Dean, O E Muniz, I Rodriquez, et al.
Nature Medicine|December 2, 1999
Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathwayM T Puglielli, J L Browning, A W Brewer, et al.
Arthritis and Rheumatism|March 4, 1998
Hip osteoarthritis prevalence estimates by three radiographic scoring systemsR Hirsch, R J Fernandes, S R Pillemer, et al.
Nature Medicine|February 1, 2002
Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substratesLuzheng Liu, Ann Chahroudi, Guido Silvestri, et al.
Immunity|November 7, 1998
Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]J J Boniface, J D Rabinowitz, C Wülfing, et al.
Arthritis and Rheumatism|November 1, 1987
Radiographic assessment of progression in osteoarthritisR D Altman, J F Fries, D A Bloch, et al.
The Journal of Rheumatology. Supplement|February 1, 1995
Cartilage metalloproteases in disuse atrophyR M Grumbles, D S Howell, G A Howard, et al.
The Journal of Rheumatology|July 15, 2003
Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteriaThao Pham, Désirée Van Der Heijde, Marissa Lassere, et al.
Cartilage|September 13, 2021
Risk of Severe Acute Localized Reactions for Different Intraarticular Hyaluronic Acid Knee Injections in a Real-World SettingKevin L Ong, Jack Farr, Andrew S Gudeman, et al.
Postgraduate Medicine|April 28, 2015
Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety studyRoy D Altman, Vibeke Strand, Marc C Hochberg, et al.
Pageof 62

Showing results (461-470 of 618) with videos related to

Sort By:
Pageof 62
Arthritis and Rheumatism|March 1, 1991
Amelioration of lapine osteoarthritis by treatment with glycosaminoglycan-peptide association complex (Rumalon)D D Dean, O E Muniz, I Rodriquez, et al.
Nature Medicine|December 2, 1999
Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathwayM T Puglielli, J L Browning, A W Brewer, et al.
Arthritis and Rheumatism|March 4, 1998
Hip osteoarthritis prevalence estimates by three radiographic scoring systemsR Hirsch, R J Fernandes, S R Pillemer, et al.
Nature Medicine|February 1, 2002
Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substratesLuzheng Liu, Ann Chahroudi, Guido Silvestri, et al.
Immunity|November 7, 1998
Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]J J Boniface, J D Rabinowitz, C Wülfing, et al.
Arthritis and Rheumatism|November 1, 1987
Radiographic assessment of progression in osteoarthritisR D Altman, J F Fries, D A Bloch, et al.
The Journal of Rheumatology. Supplement|February 1, 1995
Cartilage metalloproteases in disuse atrophyR M Grumbles, D S Howell, G A Howard, et al.
The Journal of Rheumatology|July 15, 2003
Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteriaThao Pham, Désirée Van Der Heijde, Marissa Lassere, et al.
Cartilage|September 13, 2021
Risk of Severe Acute Localized Reactions for Different Intraarticular Hyaluronic Acid Knee Injections in a Real-World SettingKevin L Ong, Jack Farr, Andrew S Gudeman, et al.
Postgraduate Medicine|April 28, 2015
Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety studyRoy D Altman, Vibeke Strand, Marc C Hochberg, et al.
Pageof 62